CircuLite Raises Second Round

CircuLite Inc., a Hackensack, N.J.-based developer of circulatory assist technology for the management of chronic heart failure, has raised $20 million in Series B funding. Foundation Medical Partners led the deal, and was joined by SB Life Science Ventures and return backers Forbion Capital Partners and Oxford Biosciences Partners.